Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs Lipocine Inc. (LPCN)

Cellectar Biosciences, Inc. and Lipocine Inc. are both Biotechnology companies. Lipocine Inc. is the larger, with a market value of $12.6M against $10.9M — 1.2× the size. Cellectar Biosciences, Inc. has the higher net margin (0.00% vs −249.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Lipocine Inc. leads on 7 and Cellectar Biosciences, Inc. on 6.

Valuation

Metric CLRB LPCN Biotechnology median
P/E n/m n/m 10.26
P/S n/m 3.37 9.18
P/B 0.48 0.60 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.83 0.58 0.65
EV/Sales n/m (1.58) 8.98
Earnings yield (395.97%) (88.89%) (34.89%)
Free cash flow yield (137.75%) (80.16%) (24.52%)

Profitability

Metric CLRB LPCN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (269.05%) 0.00%
Net margin 0.00% (249.16%) 0.00%
Free cash flow margin 0.00% (267.37%) 0.00%
Return on equity (125.99%) (52.86%) (50.12%)
Return on assets (88.70%) (47.52%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB LPCN Biotechnology median
Revenue growth (TTM) — (13.36%) 6.26%
EPS growth (last fiscal year) 80.07% (93,988.89%) 29.88%
Revenue growth, 5-year CAGR — 64.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB LPCN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 11.36 4.89
Net debt to EBITDA 0.58 1.42 1.01

Dividend

Metric CLRB LPCN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLRB LPCN Biotechnology median
Market cap 10.87m 12.61m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack